Cargando…

Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange

BACKGROUND: Traditional management of non‐steroidal anti‐inflammatory drug (NSAID) intoxication includes gastrointestinal decontamination, intravenous administration of fluids (IVF), and gastroprotection. Intravenous administration of lipid emulsion (ILE) and therapeutic plasma exchange (TPE) are po...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalifoux, Nolan V., Butty, Emmanuelle M., Mauro, Katie D., Moyle, Rachel B., Ehrhardt, Caryn M., Robertson, James B., Labato, Mary A., Culler, Christine A., Londoño, Leonel A., Vigani, Alessio, Ueda, Yu, Suter, Steven E., Lynch, Alex M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889694/
https://www.ncbi.nlm.nih.gov/pubmed/36453531
http://dx.doi.org/10.1111/jvim.16603
_version_ 1784880787525468160
author Chalifoux, Nolan V.
Butty, Emmanuelle M.
Mauro, Katie D.
Moyle, Rachel B.
Ehrhardt, Caryn M.
Robertson, James B.
Labato, Mary A.
Culler, Christine A.
Londoño, Leonel A.
Vigani, Alessio
Ueda, Yu
Suter, Steven E.
Lynch, Alex M.
author_facet Chalifoux, Nolan V.
Butty, Emmanuelle M.
Mauro, Katie D.
Moyle, Rachel B.
Ehrhardt, Caryn M.
Robertson, James B.
Labato, Mary A.
Culler, Christine A.
Londoño, Leonel A.
Vigani, Alessio
Ueda, Yu
Suter, Steven E.
Lynch, Alex M.
author_sort Chalifoux, Nolan V.
collection PubMed
description BACKGROUND: Traditional management of non‐steroidal anti‐inflammatory drug (NSAID) intoxication includes gastrointestinal decontamination, intravenous administration of fluids (IVF), and gastroprotection. Intravenous administration of lipid emulsion (ILE) and therapeutic plasma exchange (TPE) are popular novel therapeutic strategies. HYPOTHESIS: Compare outcomes of dogs treated with IVF, ILE, and TPE for NSAID intoxications and evaluate outcome predictors for drug subgroups. ANIMALS: Four hundred thirty‐four dogs with NSAID intoxications (2015‐2020). METHODS: Multicenter retrospective study of ibuprofen, carprofen, and naproxen intoxication. An ordinal outcome was defined as mild gastrointestinal, moderate kidney, or signs of severe central nervous system disease. RESULTS: Signs of neurological disease were overrepresented and acute kidney injury underrepresented in the TPE group among dogs exposed to kidney‐ or CNS‐toxic doses (P = .05), though all TPE dogs with signs of neurological disease had evidence of neurotoxicity at presentation. Dogs treated with IVF had a higher maximal creatinine concentration (median, 1.1 mg/dL; range, 0.4‐8.44 mg/dL) compared with IVF + ILE (median, 0.9 mg/dL; range, 0.4‐6.2 mg/dL; P = .01). Increased maximum time to presentation (P < .001), higher baseline creatinine (P < .001) and PCV (P = .007), and absence of induced emesis (P < .001) were associated with greater clinical severity. Ibuprofen toxicosis was associated with more severe clinical signs compared with carprofen (P = .03). Overall survival rate was 99%. CONCLUSIONS AND CLINICAL IMPORTANCE: NSAID toxicosis generally carries an excellent prognosis in dogs. Despite similar outcomes of lower incidence of AKI in the TPE group, and slightly lower maximal creatinine concentration in dogs treated with ILE vs IVF alone, ILE and TPE should be considered in the management of severe NSAID toxicosis.
format Online
Article
Text
id pubmed-9889694
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-98896942023-02-02 Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange Chalifoux, Nolan V. Butty, Emmanuelle M. Mauro, Katie D. Moyle, Rachel B. Ehrhardt, Caryn M. Robertson, James B. Labato, Mary A. Culler, Christine A. Londoño, Leonel A. Vigani, Alessio Ueda, Yu Suter, Steven E. Lynch, Alex M. J Vet Intern Med SMALL ANIMAL BACKGROUND: Traditional management of non‐steroidal anti‐inflammatory drug (NSAID) intoxication includes gastrointestinal decontamination, intravenous administration of fluids (IVF), and gastroprotection. Intravenous administration of lipid emulsion (ILE) and therapeutic plasma exchange (TPE) are popular novel therapeutic strategies. HYPOTHESIS: Compare outcomes of dogs treated with IVF, ILE, and TPE for NSAID intoxications and evaluate outcome predictors for drug subgroups. ANIMALS: Four hundred thirty‐four dogs with NSAID intoxications (2015‐2020). METHODS: Multicenter retrospective study of ibuprofen, carprofen, and naproxen intoxication. An ordinal outcome was defined as mild gastrointestinal, moderate kidney, or signs of severe central nervous system disease. RESULTS: Signs of neurological disease were overrepresented and acute kidney injury underrepresented in the TPE group among dogs exposed to kidney‐ or CNS‐toxic doses (P = .05), though all TPE dogs with signs of neurological disease had evidence of neurotoxicity at presentation. Dogs treated with IVF had a higher maximal creatinine concentration (median, 1.1 mg/dL; range, 0.4‐8.44 mg/dL) compared with IVF + ILE (median, 0.9 mg/dL; range, 0.4‐6.2 mg/dL; P = .01). Increased maximum time to presentation (P < .001), higher baseline creatinine (P < .001) and PCV (P = .007), and absence of induced emesis (P < .001) were associated with greater clinical severity. Ibuprofen toxicosis was associated with more severe clinical signs compared with carprofen (P = .03). Overall survival rate was 99%. CONCLUSIONS AND CLINICAL IMPORTANCE: NSAID toxicosis generally carries an excellent prognosis in dogs. Despite similar outcomes of lower incidence of AKI in the TPE group, and slightly lower maximal creatinine concentration in dogs treated with ILE vs IVF alone, ILE and TPE should be considered in the management of severe NSAID toxicosis. John Wiley & Sons, Inc. 2022-12-01 /pmc/articles/PMC9889694/ /pubmed/36453531 http://dx.doi.org/10.1111/jvim.16603 Text en © 2022 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals LLC on behalf of American College of Veterinary Internal Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle SMALL ANIMAL
Chalifoux, Nolan V.
Butty, Emmanuelle M.
Mauro, Katie D.
Moyle, Rachel B.
Ehrhardt, Caryn M.
Robertson, James B.
Labato, Mary A.
Culler, Christine A.
Londoño, Leonel A.
Vigani, Alessio
Ueda, Yu
Suter, Steven E.
Lynch, Alex M.
Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
title Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
title_full Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
title_fullStr Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
title_full_unstemmed Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
title_short Outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
title_sort outcomes of 434 dogs with non‐steroidal anti‐inflammatory drug toxicosis treated with fluid therapy, lipid emulsion, or therapeutic plasma exchange
topic SMALL ANIMAL
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889694/
https://www.ncbi.nlm.nih.gov/pubmed/36453531
http://dx.doi.org/10.1111/jvim.16603
work_keys_str_mv AT chalifouxnolanv outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT buttyemmanuellem outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT maurokatied outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT moylerachelb outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT ehrhardtcarynm outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT robertsonjamesb outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT labatomarya outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT cullerchristinea outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT londonoleonela outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT viganialessio outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT uedayu outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT suterstevene outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange
AT lynchalexm outcomesof434dogswithnonsteroidalantiinflammatorydrugtoxicosistreatedwithfluidtherapylipidemulsionortherapeuticplasmaexchange